NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in hundreds of metabolic reactions, including energy production, DNA repair, and the activation of sirtuins — proteins linked to longevity. The problem: NAD+ levels decline roughly 50% between ages 40 and 60. NMN (nicotinamide mononucleotide) is one of the most direct ways to raise them.
That's the promise. But what does the human evidence actually show?
How NMN raises NAD+
NMN is a direct precursor to NAD+. After ingestion, NMN is converted to nicotinamide riboside (NR), which is then converted to NAD+ inside cells. The pathway: NMN → NR → NMN (intracellularly) → NAD+.
A 2021 pharmacokinetic study published in Nature Metabolism confirmed that oral NMN is rapidly absorbed and does raise blood NAD+ levels in humans — settling an earlier debate about whether NMN could even enter cells intact. It can, though the pathway involves some conversion steps.
What the human trials show
The evidence base for NMN in humans is small but growing. A few notable trials:
The 2021 Keio University RCT (published in npj Aging and Mechanisms of Disease) gave 250mg/day of NMN to healthy older men for 12 weeks. Blood NAD+ levels rose significantly. Walking speed and grip strength trended upward, but the sample was small (n=25) and the results were not statistically significant for most endpoints.
The 2023 muscle physiology RCT published in Cell Metabolism (Washington University, St. Louis) was more rigorous. Postmenopausal women with prediabetes received 250mg/day of NMN for 10 weeks. Results: improved muscle insulin sensitivity and expression of genes involved in energy metabolism. This was a well-designed, placebo-controlled trial and represents one of the strongest pieces of human evidence to date.
MIB-626, a pharmaceutical-grade NMN formulation developed by Metro International Biotech, has entered human trials at higher doses (1000mg and above). Early results show robust NAD+ elevation, but efficacy data on longevity or disease endpoints are not yet published.
Dosage and delivery
Most human trials have used 250-500mg/day. Some researchers, including David Sinclair at Harvard, have taken 1g/day personally — though this is self-experimentation, not a clinical recommendation.
Sublingual vs. oral: There is theoretical reason to believe sublingual delivery bypasses first-pass metabolism and delivers NMN more efficiently. One small study supports faster absorption with sublingual powder. However, enteric-coated oral capsules may perform comparably. The honest answer: more direct comparison data are needed.
Timing: Morning is generally recommended, as NAD+ is involved in circadian clock regulation.
Sinclair lab research and context
David Sinclair's lab at Harvard has been central to NMN research, having published extensively on NAD+ and sirtuins. Sinclair's work in mice showed dramatic effects: old mice given NMN showed improvements in muscle endurance, energy metabolism, and markers of aging. These mouse studies drove much of the early excitement.
The critical caveat: mice metabolize NMN differently than humans, have shorter lifespans, and respond to many interventions that don't translate to people. Mouse longevity data is hypothesis-generating, not confirmatory.
Realistic expectations
NMN is not a fountain of youth. Here's what you can reasonably expect from current evidence:
- Blood NAD+ levels will likely increase measurably
- Metabolic improvements (insulin sensitivity, energy metabolism) are plausible at 250-500mg/day
- Effects on human lifespan are unknown — no long-term human data exists
- Mouse data is compelling but should not be extrapolated directly
NMN also competes with niacin (vitamin B3) for some pathways, and high-dose niacin has decades of human safety data. NMN's long-term safety profile at therapeutic doses is still being established.
The bottom line
NMN is one of the more scientifically grounded longevity supplements, with a plausible mechanism and early human trial data supporting metabolic benefits. The 2023 Cell Metabolism RCT is particularly encouraging. That said, we're still in early innings — most human trials are small, short, and don't measure the outcomes that matter most (lifespan, disease incidence).
If you're considering NMN, 250-500mg/day in the morning is a reasonable starting point based on current evidence. Expect to raise your NAD+ levels. Don't expect to reverse aging.
Want to track whether NMN is actually making a difference for your energy and metabolic markers? Use Optimize free.
Related Articles
- The Best Anti-Aging Supplement Stack (What Actually Works)
- NMN Supplement Guide: NAD+ Boosting for Longevity and Health
- Best Supplements for Healthy Aging and Longevity: Evidence-Based Guide
- Best Supplements for Longevity and Healthy Aging
- Caloric Restriction Mimetics: Supplements That Mimic Fasting
Related Supplement Interactions
Learn how these supplements interact with each other
Related Articles
More evidence-based reading
Akkermansia Muciniphila: The Gut Bacteria That Affects Metabolism and Weight
Akkermansia muciniphila is a keystone gut bacterium whose abundance strongly predicts metabolic health, gut barrier integrity, and response to weight loss interventions — and it can be deliberately cultivated.
8 min read →Resistant Starch for Gut Health: The Prebiotic That Changes Body Composition
Resistant starch is one of the few dietary compounds with simultaneous evidence for improving gut microbiome diversity, reducing postprandial glucose, and improving body composition — through mechanisms that are now well understood.
9 min read →Butyrate Supplements: What This Short-Chain Fatty Acid Does for Your Gut
Butyrate is the primary fuel source for colon cells and a critical regulator of gut barrier function, inflammation, and even gene expression — but supplementing it effectively is more complicated than it appears.
8 min read →